What is Johnson & Johnson's other commercial liabilities?

Johnson & Johnson (JNJ) reported other commercial liabilities of $9.46B in Q2 2026.

How has Johnson & Johnson's other commercial liabilities changed year-over-year?

Johnson & Johnson's other commercial liabilities increased by 27.8% year-over-year, from $7.4B to $9.46B.

What is the long-term trend for Johnson & Johnson's other commercial liabilities?

Over 5 years (2020 to 2025), Johnson & Johnson's other commercial liabilities has grown at a -9.3% compound annual growth rate (CAGR), from $13.97B to $8.59B.

Johnson & Johnson JNJ Other Commercial Liabilities

Other Commercial Liabilities at other companies

Procter & GamblePG

——

Merit Medical SystemsMMSI

——

Boston ScientificBSX

——

PenumbraPEN

——

Vor BiopharmaVOR

——

Bausch + LombBLCO

——

Other financials

Income statement

See full

Revenue$25.3B+6.6%

Gross profit$17.3B+7.1%

Operating income$7.1B+7.4%

Net income$5.5B-0.1%

EPS (diluted)$2.27-0.9%

Balance sheet

See full

Cash & equivalents$20.4B+9.9%

Total debt$49.0B-3.4%

Total equity$85.0B+8.3%

Total assets$201.06B+4.0%

Cash flow

See full

Operating cash flow$8.6B+122%

CapEx$1.3B+26.7%

Free cash flow$7.3B+157%

Valuation

See full

Market cap$634.77B+58.6%

Enterprise value$663.38B+53.4%

P/E30.2×+12.5×

P/S6.5×+2.1×

Profitability

See full

Gross margin67.9%0.0pp

Operating margin26.5%+2.8pp

Net margin21.5%-3.5pp

FCF margin22.7%+2.2pp

Returns & leverage

See full

Return on equity25.7%-4.5pp

Debt / equity0.6×-0.1×

Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Johnson & Johnson’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's other commercial liabilities?: Johnson & Johnson (JNJ) reported other commercial liabilities of $9.46B in Q2 2026.
How has Johnson & Johnson's other commercial liabilities changed year-over-year?: Johnson & Johnson's other commercial liabilities increased by 27.8% year-over-year, from $7.4B to $9.46B.
What is the long-term trend for Johnson & Johnson's other commercial liabilities?: Over 5 years (2020 to 2025), Johnson & Johnson's other commercial liabilities has grown at a -9.3% compound annual growth rate (CAGR), from $13.97B to $8.59B.